The Effect of Oxytocin on Face Perception

Soroka University Medical Center

Status and phase: Suspended; Early Phase 1

Conditions: Congenital Prosopagnosia; Healthy

Treatments: Drug: Oxytocin; Drug: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT02091817

sor010712ctil

ISF, 384/10 (Other Grant/Funding Number)

Details and patient eligibility

About

The purpose of this study is to determine whether oxytocin affect face perception

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• normal or corrected to normal vision

Exclusion criteria

• minors
• pregnancy (according to a pregnancy test taken by subjects prior to participation)
• a history of asthma or nasal polyps
• cardiac disorders
• hyponatremia
• acute or chronic renal insufficiency
• liver cirrhosis
• neurological disease
• other chronic disease
• dementia, or lack of judgment

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind

---

100 participants in 2 patient groups

Control group

Other group

Description:

Control group will be administered oxytocin and placebo, in a double-blind randomized order.

Treatment:

Drug: Placebo

Drug: Oxytocin

congenital prosopagnosia

Experimental group

Description:

Congenital prosopagnosics will be administered oxytocin and placebo in a double-blind randomized order.

Treatment:

Drug: Placebo

Drug: Oxytocin